For patients with type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a reduced ...
3d
News-Medical.Net on MSNGLP-1 drugs may cut risk of leukemia and lymphoma in type 2 diabetes patientsResearchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...
2d
HealthDay on MSNRisk for Specific Hematologic Cancers Down With GLP-1 Receptor Agonist Use in T2DMFor patients with type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a ...
Beyond type 2 diabetes and weight loss, GLP-1 agonists can also help lower blood pressure, improve lipid disorders, reduce ...
Glucagon-like peptide 1 receptor agonists appear to reduce the risk of age-related macular degeneration and primary open-angle glaucoma.
6d
HealthDay on MSNGLP-1 Drugs Improve Outlook For Kidney TransplantsGLP-1 drugs like Ozempic can help kidney transplant patients avoid organ failure and live longer, a new study sugges ...
Dr. Troy Mensen is a family medicine doctor based in the Chicago area. He completed his undergraduate degree at the University of Northern Iowa and his doctorate at Des Moines University College ...
A Central Illinois cardiologist breaks down the potential benefits of GLP-1 medications on heart health. It was one of the ...
The researchers note that GLP-1 drugs offer protection by reducing harmful brain proteins, inflammation, and insulin resistance. At the same time, the findings for clinical studies were more mixed, ...
I’m trying to lose the 18 pounds I have gained since the pandemic. It has been hard enough that I’m wondering about Ozempic. How does that work? I’m ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results